Fri, March 24, 2023
Thu, March 23, 2023
Wed, March 22, 2023
Tue, March 21, 2023
Mon, March 20, 2023
Sat, March 18, 2023
Fri, March 17, 2023
Thu, March 16, 2023

William Pickering Initiated (ALLO) at Hold and Held Target at $6 on, Mar 21st, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -hold-and-held-target-at-6-on-mar-21st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

William Pickering of Bernstein, Initiated "Allogene Therapeutics, Inc." (ALLO) at Hold and Held Target at $6 on, Mar 21st, 2023.

William has made no other calls on ALLO in the last 4 months.



There are 9 other peers that have a rating on ALLO. Out of the 9 peers that are also analyzing ALLO, 1 agrees with William's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Benjamin Chaiken of "JMP Securities" Maintained at Hold with Decreased Target to $19 on, Thursday, March 2nd, 2023


These are the ratings of the 8 analyists that currently disagree with William


  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $31 on, Thursday, March 2nd, 2023
  • Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $15 on, Wednesday, March 1st, 2023
  • Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $22 on, Wednesday, March 1st, 2023
  • Mark Breidenbach of "Oppenheimer" Maintained at Buy with Decreased Target to $28 on, Wednesday, March 1st, 2023
  • Brian Cheng of "JP Morgan" Upgraded from Hold to Buy and Decreased Target to $11 on, Tuesday, January 24th, 2023
  • Jack Allen of "Baird" Upgraded from Hold to Buy and Held Target at $12 on, Friday, January 6th, 2023
  • Jason Gerberry of "B of A Securities" Downgraded from Strong Buy to Sell and Held Target at $9 on, Monday, December 12th, 2022
  • Debjit Chattopadhyay of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $29 on, Monday, November 21st, 2022

Publication Contributing Sources